You are here » Home » Companies » Company Overview » Shivalik Rasayan Ltd

Shivalik Rasayan Ltd.

BSE: 539148 Sector: Agri and agri inputs
NSE: N.A. ISIN Code: INE788J01021
BSE 00:00 | 17 Jul 309.95 -0.40
(-0.13%)
OPEN

305.05

HIGH

314.95

LOW

285.00

NSE 05:30 | 01 Jan Shivalik Rasayan Ltd
OPEN 305.05
PREVIOUS CLOSE 310.35
VOLUME 8876
52-Week high 392.00
52-Week low 162.80
P/E 63.51
Mkt Cap.(Rs cr) 326
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 305.05
CLOSE 310.35
VOLUME 8876
52-Week high 392.00
52-Week low 162.80
P/E 63.51
Mkt Cap.(Rs cr) 326
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Shivalik Rasayan Ltd. (SHIVALIKRASAYAN) - Chairman Speech

Company chairman speech

Dear Shareholders

Business growth with a value-centric approach is an important element of the corporateculture at SRL. Our business interest work in harmony with society's interest.We buildproducts that just not function but bring welfare to the society and most importantlyblessings to people's lives. We have continuously explored new ideas innovative chemistryto meet customer demand and create value with special focus on environment protection.

The year 2016-17 was a constructive year for the Company as we dedicatedly pursuedgrowth opportunities generated steady revenues and healthy profit. I am happy to sharethe key financial highlights for the year 2016-17 as below: EBIDTA grew from ` 5.41 croresto ` 7.29 crores recording a growth rate of 34.75% over the previous year Net profit grewfrom ` 2.66 crores to ` 3.30 crores recording a growth rate of 24.06% over theprevious year

On the operational front we are setting up a new green field ultra modernmanufacturing facility at Dahej-II in Gujrat. Aligned with the Government's ‘Make inIndia' initiative this is a significant move ahead to fill up the substantial gap betweendemand and supply. The facility has already received necessary environmental clearances.We look forward to exploring the tremendous growth opportunity lying ahead of us. We willenhance our focus towards manufacturing bulk chemicals speciality chemicals as well asAPIs. The acquisition of Medicamen Biotech Limited during the previous year furtherprovides the Company to explore the backward growth potential across the pharma valuechain. I take this opportunity to express my gratitude to the Company's shareholdersinvestors bankers and customers for their continued support patronage and goodwill. Welook forward to implementing our planned strategic initiatives towards generating qualitybusiness growth and value creation. I seek your continued support to take your Company togreater heights.

Warm Wishes

RAHUL BISHNOI